[go: up one dir, main page]

SI2070536T1 - Farmacevtska sestava vsebujoča derivat fenilamidina in postopek z uporabo farmacevtske sestave vkombinaciji s protiglivičnim sredstvom - Google Patents

Farmacevtska sestava vsebujoča derivat fenilamidina in postopek z uporabo farmacevtske sestave vkombinaciji s protiglivičnim sredstvom

Info

Publication number
SI2070536T1
SI2070536T1 SI200730827T SI200730827T SI2070536T1 SI 2070536 T1 SI2070536 T1 SI 2070536T1 SI 200730827 T SI200730827 T SI 200730827T SI 200730827 T SI200730827 T SI 200730827T SI 2070536 T1 SI2070536 T1 SI 2070536T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical composition
antifungal agents
combination
phenylamidine derivative
agents
Prior art date
Application number
SI200730827T
Other languages
English (en)
Inventor
Hiroshi Nishikawa
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of SI2070536T1 publication Critical patent/SI2070536T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200730827T 2006-10-06 2007-10-03 Farmacevtska sestava vsebujoča derivat fenilamidina in postopek z uporabo farmacevtske sestave vkombinaciji s protiglivičnim sredstvom SI2070536T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006274709 2006-10-06

Publications (1)

Publication Number Publication Date
SI2070536T1 true SI2070536T1 (sl) 2012-03-30

Family

ID=39282771

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200730827T SI2070536T1 (sl) 2006-10-06 2007-10-03 Farmacevtska sestava vsebujoča derivat fenilamidina in postopek z uporabo farmacevtske sestave vkombinaciji s protiglivičnim sredstvom

Country Status (21)

Country Link
US (1) US8173157B2 (sl)
EP (1) EP2070536B1 (sl)
JP (1) JP5132569B2 (sl)
KR (1) KR101409258B1 (sl)
CN (1) CN101522195B (sl)
AT (1) ATE538789T1 (sl)
AU (1) AU2007305626B2 (sl)
BR (1) BRPI0719157A2 (sl)
CA (1) CA2664915C (sl)
CY (1) CY1112617T1 (sl)
DK (1) DK2070536T3 (sl)
ES (1) ES2376130T3 (sl)
MX (1) MX2009003533A (sl)
NO (1) NO20091101L (sl)
NZ (1) NZ575714A (sl)
PL (1) PL2070536T3 (sl)
PT (1) PT2070536E (sl)
RU (1) RU2429843C2 (sl)
SI (1) SI2070536T1 (sl)
WO (1) WO2008044562A1 (sl)
ZA (1) ZA200902053B (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
TW200841879A (en) 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
TWI395735B (zh) 2007-07-04 2013-05-11 Toyama Chemical Co Ltd ４－｛３－〔４－（３－｛４－〔胺基（丁氧基羰基亞胺基）甲基〕苯氧基｝丙基）－１－哌啶基〕丙氧基｝－ｎ’－（丁氧基羰基）苄脒之新穎結晶
JPWO2012060448A1 (ja) 2010-11-05 2014-05-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗真菌剤としての併用医薬組成物
AU2013250251B2 (en) 2012-04-20 2017-05-11 Eisai R&D Management Co., Ltd. Encapsulated formulation
IL266223B2 (en) 2016-10-31 2024-04-01 Biocryst Pharm Inc Prodrugs of kallikrein inhibitors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
JPH03288051A (ja) 1990-03-30 1991-12-18 Mazda Motor Corp カムシャフトおよびその製造方法
GB9509631D0 (en) 1995-05-12 1995-07-05 Sandoz Ltd Antifungal combination
ES2203819T3 (es) 1996-09-12 2004-04-16 MERCK & CO., INC. Terapia antifungica combinada.
AUPQ066399A0 (en) 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
DK1481966T3 (da) * 2002-03-06 2011-10-24 Toyama Chemical Co Ltd Nyt arylamidinderivat eller salt deraf
CA2537574A1 (en) * 2003-09-05 2005-03-24 Merck & Co., Inc. Stationary phases and a purification process using the stationary phases
JP4937506B2 (ja) * 2003-09-05 2012-05-23 富山化学工業株式会社 新規なアリールアミジン誘導体またはその塩
BRPI0512661B8 (pt) * 2004-06-30 2021-05-25 Fujifilm Toyama Chemical Co Ltd derivado de arilamidina ou um sal do mesmo, composto ou um sal do mesmo, e, composto antifúngico
CN1596897A (zh) * 2004-07-26 2005-03-23 范敏华 一种伊曲康唑注射剂及其制备方法
JP5021308B2 (ja) * 2004-07-28 2012-09-05 富山化学工業株式会社 新規なアリールアミジン誘導体およびその塩ならびにそれらを含有する抗真菌剤
US8993603B2 (en) * 2005-04-07 2015-03-31 Toyama Chemical Co., Ltd. Pharmaceutical composition and method using antifungal agent in combination
WO2007055197A1 (ja) 2005-11-09 2007-05-18 Toyama Chemical Co., Ltd. ４－（３－（４－（３－（４－シアノフェノキシ）プロピル）－１－ピペリジニル）プロポキシ）ベンゾニトリルの製造法およびその中間体
JP5038155B2 (ja) * 2005-12-29 2012-10-03 富山化学工業株式会社 新規なアリールアミジン誘導体およびその塩ならびにそれらを含有する抗真菌剤

Also Published As

Publication number Publication date
AU2007305626A1 (en) 2008-04-17
JPWO2008044562A1 (ja) 2010-02-12
CA2664915A1 (en) 2008-04-17
PL2070536T3 (pl) 2012-06-29
CY1112617T1 (el) 2016-02-10
KR20090069317A (ko) 2009-06-30
NO20091101L (no) 2009-04-27
EP2070536A4 (en) 2010-02-10
RU2009117207A (ru) 2010-11-20
ES2376130T3 (es) 2012-03-09
MX2009003533A (es) 2009-07-17
DK2070536T3 (da) 2012-04-10
CA2664915C (en) 2014-01-07
WO2008044562A1 (fr) 2008-04-17
KR101409258B1 (ko) 2014-06-18
BRPI0719157A2 (pt) 2014-02-04
US20100098750A1 (en) 2010-04-22
CN101522195B (zh) 2012-01-18
PT2070536E (pt) 2012-03-06
AU2007305626B2 (en) 2013-01-10
EP2070536B1 (en) 2011-12-28
CN101522195A (zh) 2009-09-02
NZ575714A (en) 2011-05-27
ATE538789T1 (de) 2012-01-15
JP5132569B2 (ja) 2013-01-30
RU2429843C2 (ru) 2011-09-27
EP2070536A1 (en) 2009-06-17
ZA200902053B (en) 2010-07-28
US8173157B2 (en) 2012-05-08

Similar Documents

Publication Publication Date Title
MX337779B (es) Amidas azociclicas fungicidas.
WO2009094407A3 (en) Fungicidal amides
NL301039I1 (nl) Fostamatinib of een farmaceutisch aanvaardbaar zout van fostamatinib, of een hydraat, solvaat of N-oxide van fostamatinib of het farmaceutisch aanvaardbare zout van fostamatinib, in het bijzonder dinatriumfostamatinib eventueel in de vorm van een hydraat
WO2010065579A3 (en) Fungicidal heterocyclic compounds
WO2008091580A3 (en) Fungicidal amides
UA90209C2 (ru) Фунгицидная композиция, способ борьбы с заболеваниями полезных растений и способ защиты товаров
CY1112237T1 (el) Παραγωγα 5-υδροξυ-βενζοθειαζολης που εχουν ενεργοτητα αγωνιστη βητα-2-αδρενοϋποδοχεα
MX2010008102A (es) Compuestos fungicidas heterociclicos.
WO2012082580A3 (en) Fungicidal azocyclic amides
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
MX2010001004A (es) Derivados de n-cicloalquil-bencil-tiocarboxamida o n-cicloalquil-bencil-amidina-n´-sustituida como fungicidas.
EP2532237A3 (en) Substituted benzene fungicides
MX2009008411A (es) Ectoparasiticida de accion prolongada con alta dosis para un control prolongado.
ZA200902053B (en) Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
MX2007000392A (es) Derivados de 2-pirrolidona sustituida como fungicidas e insecticidas.
WO2010021934A3 (en) Azaindole inhibitors of iap
UA105639C2 (uk) Протигрибковий засіб
MY153861A (en) Composition and method for controlling pests
UA92180C2 (en) Benzimidazole thiophene compounds as plk inhibitors
WO2007088116A3 (de) Fungizide mischungen enthaltend epoxiconazol und metiram
TW200738606A (en) Thioamide compounds for combating animal pest
UA101598C2 (ru) Фунгицидные азоциклические амиды, способ борьбы с болезнями растений и фунгицидные композиции
HRP20070428T3 (en) Fungicide mixtures
TH151174A (th) สารต้านเชื้อรา